New injection could offer days of pain relief after lung surgery
NCT ID NCT06165991
Summary
This study is testing whether a new, long-acting numbing medicine (liposomal bupivacaine) works better than the standard version for pain control after minimally invasive lung surgery. Researchers will give the injection near the spine to block pain nerves and measure how well it controls pain and reduces the need for opioid painkillers over several days. The goal is to help patients recover more comfortably with fewer side effects from strong pain medications.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POSTOPERATIVE ANALGESIA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Qianfoshan Hospital, The First Hospital affiliated of Shandong First Medical University
RECRUITINGJinan, Shandong, 250014, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.